Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy.

NCT01666236 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT01666236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy.
Lead sponsor
Federal University of São Paulo
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2012
Completion date
September 30, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascularization, retinal pigment epithelial detachment